Lucid Diagnostics annual revenue
2021
2022
2023
2024
2025
Lucid Diagnostics reported $4.7M in revenue for fiscal 2025, an increase of 8.28% from the previous fiscal year.
View full Lucid Diagnostics company overview| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $4.7M | $360,000 | +8.28% |
| 2024 | 2024-12-31 | $4.3M | $1.9M | +79.00% |
| 2023 | 2023-12-31 | $2.4M | $2.1M | +544.03% |
| 2022 | 2022-12-31 | $377,000 | −$123,000 | −24.60% |
| 2021 | 2021-12-31 | $500,000 | — | — |
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.5M | $311,000 | +26.74% |
| Q1 2026 | 2026-03-31 | $1.3M | $428,000 | +51.69% |
| Q4 2025 | 2025-12-31 | $1.5M | $307,000 | +25.65% |
| Q3 2025 | 2025-09-30 | $1.2M | $39,000 | +3.33% |
| Q2 2025 | 2025-06-30 | $1.2M | $187,000 | +19.16% |
| Q1 2025 | 2025-03-31 | $828,000 | −$173,000 | −17.28% |
| Q4 2024 | 2024-12-31 | $1.2M | $157,000 | +15.10% |
| Q3 2024 | 2024-09-30 | $1.2M | $389,000 | +49.68% |
| Q2 2024 | 2024-06-30 | $976,000 | $817,000 | +513.84% |
| Q1 2024 | 2024-03-31 | $1.0M | $555,000 | +124.44% |
| Q4 2023 | 2023-12-31 | $1.0M | $928,000 | +828.57% |
| Q3 2023 | 2023-09-30 | $783,000 | $707,000 | +930.26% |
| Q2 2023 | 2023-06-30 | $159,000 | $159,000 | — |
| Q1 2023 | 2023-03-31 | $446,000 | $257,000 | +135.98% |
| Q4 2022 | 2022-12-31 | $112,000 | — | — |
| Q3 2022 | 2022-09-30 | $76,000 | −$124,000 | −62.00% |
| Q2 2022 | 2022-06-30 | $0 | — | — |
| Q1 2022 | 2022-03-31 | $189,000 | — | — |
| Q3 2021 | 2021-09-30 | $200,000 | — | — |
Lucid Diagnostics's latest reported quarter, Q2 2026, generated $1.5M in revenue, an increase of 26.74% year over year.
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Lucid Diagnostics source filings ↗